- Understand treatment progression for patients with early-stage Parkinson Disease (PD).
- Discuss the role of immediate- and extended-release formulations of levodopa with carbidopa formulations for motor fluctuations.
- Share best practices for adopting novel therapies.
New Horizons in Immediate- And Extended-Release Levodopa With Carbidopa Formulations for Parkinson Disease
Tuesday, September 9, 2025
7:00 PM - 9:00 PM ET
The Capital Grille, 900 Boylston St, Boston, MA 02115
OVERVIEW
NeurologyLive® Clinical Forum are regional roundtable discussions where an expert moderator has the opportunity to directly engage with neurologists to present data, medical advances, and patient case scenarios. This leads to a moderated forum between attendees to gather insights on their community practice implementation of new science, feedback on case scenarios, as well as other information which impact the clinical decision making of local neurologists.
These forums serve as a platform for localized education and peer-to-peer collaborative discussions aiming to ultimately elevate and improve patient care.
LEARNING OBJECTIVES
Venue Location
MARKET RESEARCH PARTICIPATION
This event is held in partnership with Healthcare Research & Analytics® to gain market research insights into health care professional’s educational needs in their current practice setting.
HR&A offers compensation of $500 to physicians for your consultative contributions during the event discussions, responses to polling questions and completion of a post-event survey.
Copyright NeurologyLive 2025.
All Rights Reserved.
Privacy Policy
Contact Us: events@neurologylive.com